Day 1: Thursday, May 9, 2024
Welcome and Opening Remarks
Wendy Weber, ND, PhD, MPH; Lesley Curtis, PhD
Feature major accomplishments of the program; review specific requirements for the new trials; offer guidance and answer questions
Wendy Weber, ND, PhD, MPH
Hear from the NIH Collaboratory Trials about ethical and regulatory challenges encountered; Discuss strategies for navigating ethical and regulatory complexities of ePCTs
Moderator: Stephanie Morain, PhD
Panel:
- Michele Balas, PhD, RN, CCRN-K, FCCM, FAAN
- Diana Burgess, PhD
- Richard Skolasky, ScD, MA
Learn about study design issues faced by the NIH Collaboratory Trials; Share statistical and methodological considerations important for the planning phase and beyond
Moderator: Patrick Heagerty, PhD
Panel:
-
Sheana Bull, PhD, MPH
- Stephanie Fitzpatrick, PhD
- Chenchen Wang, MD, MSc
Hear from the NIH Collaboratory Trials about challenges with data access, planning for data management, and data sharing; Review methods for addressing issues related to data security, privacy, and approval for data use
Moderator: Rachel Richesson, PhD, MPH, MS, FACMI
Panel:
Share progress on ePCTs for the prevention and management of chronic pain in rural populations, describing challenges and lessons learned; Begin communication that may lead to joint publications on methods and strategies, and/or future collaborations
Moderators: Karen Kehl, PhD, RN, FPCN
Panel:
Welcome and Introduction of Fireside Chat
Welcome participants, introduce the Fireside Chat, and kick off the afternoon session for all NIH Collaboratory Trials
Helene Langevin, MD, PhD; Richard Hodes, MD; David Shurtleff, PhD
Hear thoughts on how pragmatic research can help address the nation’s top health priorities; Discuss how to maximize evidence generation from ePCTs and achieve the greatest benefits for the U.S. population
Moderator: Wendy Weber, ND, PhD, MPH
Guests:
- Monica Bertagnolli, MD
- Robert Califf, MD
Share an overview of the characteristics of trials in the NIH Collaboratory, such as populations, partner types (e.g., hospitals, primary care, community clinics, FQHCs); Discuss the evolution of the program and identify gaps and areas of opportunity
Kevin Weinfurt, PhD
Describe barriers to conducting ePCTs involving approved drugs, including trials with repurposed drugs and A vs B trials; Explore potential ways to overcome these barriers, including how the NIH Collaboratory might contribute
Moderator: Adrian Hernandez, MD, MHS
Panel:
- Pearl O'Rourke, MD
- Kevin Bugin, PhD
- Leonard Sacks, MD
- Tracy Wang, MD, MHS, MSc
Review the Coordinating Center’s efforts to support patient engagement; Hear from NIH Collaboratory Trials on challenges and methods for engaging patients in ePCTs
Moderator: Steven George, PT, PhD
Panel:
- Natalia Morone, MD, MS
- Chenchen Wang, MD, MSc
Hear flash talks from NIH Collaboratory fellows
Moderator: Emily O'Brien, PhD
Presenters:
- Lindsay Ballangee, DPT
- Kaitlyn McLeod, MD
Closing Remarks
Wendy Weber, ND, PhD, MPH; Lesley Curtis, PhD